Jonathan Behr – Biography
Last update: February 8, 2026Executive profile
Jonathan was Board Observer at Diasome Pharmaceuticals, and Board Observer at Semma Therapeutics. Jonathan Behr joined SV Health Investors in 2019.
Jonathan Behr is currentlyPartner, United States at Dementia Discovery Fund - View - Dementia Discovery Fund org chart
Partner, Therapeutics at SV Health Investors - View - SV Health Investors org chart
Director at Nitrase Therapeutics - View - Nitrase Therapeutics org chart
Create your alert
to follow the career of Jonathan Behr.
Education
Jonathan Behr has a Bachelor of Science in Bioengineering from Rice University in 2002 and a Doctor of Philosophy, Biological Engineering from Massachusetts Institute of Technology in 2007.
They have also studied at Rice University :
Find more alumni from Rice University
They have also studied at Massachusetts Institute of Technology :
Find more alumni from Massachusetts Institute of Technology
More about Jonathan Behr
Selected links
Do you need to know more about Jonathan Behr? More results.
Participate
Social media
- Jonathan Behr on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Jonathan Behr
The colleagues of Jonathan Behr
Company Colleagues
- At Dementia Discovery Fund, Jonathan Behr has 16 colleagues including Kate Bingham (Managing Partner), Mike Ross (Senior Partner)…
- At SV Health Investors, Jonathan Behr has 65 colleagues including Eugene Hill (Chairman of the Board), Paul LaViolette (COO & Medical Technology)…
- At Nitrase Therapeutics, Jonathan Behr has 6 colleagues including Irene Griswold-Prenner (CEO & Science), Perry Karsen (Director)…
Industry Colleagues
- In the Fund industry, Jonathan Behr has 30,040 colleagues in 1,643 companies located in 64 countries. 10,519 executive movements have been recorded in the last 12 months. Learn more about Fund.
Report an error
Update the org chart details of Jonathan Behr.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Jonathan Behr.
